deltatrials
Completed NCT00000623

Thalassemia (Cooley's Anemia) Clinical Research Network (TCRN)

Thalassemia Clinical Research Network (TCRN)

Sponsor: Carelon Research

Conditions Anemia, Cooley's Beta-Thalassemia Hematologic Diseases Hypertension, Pulmonary Iron Overload Osteoporosis Thalassemia
Interventions Arginine Decitabine Deferiprone Deferoxamine Sildenafil
Updated 8 times since 2017 Last updated: Mar 3, 2014 Started: Jul 31, 2000 Completion: Jul 31, 2006

Listed as NCT00000623, this observational or N/A phase trial focuses on Anemia, Cooley's and Beta-Thalassemia and remains completed. Sponsored by Carelon Research, it has been updated 8 times since 2000, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Change History

8 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed

  2. Jul 2024 — Sep 2024 [monthly]

    Completed

  3. Aug 2023 — Jul 2024 [monthly]

    Completed

  4. Jan 2021 — Aug 2023 [monthly]

    Completed

  5. Apr 2020 — Jan 2021 [monthly]

    Completed

▶ Show 3 earlier versions

  1. Jun 2018 — Apr 2020 [monthly]

    Completed

  2. Apr 2018 — Jun 2018 [monthly]

    Completed

    Phase: NA → None

  3. Jan 2017 — Apr 2018 [monthly]

    Completed NA

    First recorded

Jul 2000

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Carelon Research
  • National Heart, Lung, and Blood Institute (NHLBI)
  • Thalassemia Clinical Research Network
Data source: Carelon Research

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Boston, United States
  • • New York, United States
  • • Oakland, United States
  • • Philadelphia, United States
  • • Toronto, Canada